Advanced Stage Non-small Cell Lung Cancer Clinical Trial
Official title:
An Exploratory Study to Evaluate the Mediators of Sensitivity and Resistance to Nivolumab Plus Ipilimumab in Patients With Advanced NSCLCs
The purpose of this study is to closely examine tumor and blood samples from patients treated with nivolumab and ipilimumab in order to try to identify why some patients with lung cancers respond and why some patients do not.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05701176 -
A Clinical Imaging Study of the Changes in [18F]F-AraG Uptake Following Anti-PD-1 Therapy in Non-small Cell Lung Cancer
|
N/A |